A detailed history of Hexagon Capital Partners LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 42 shares of LNTH stock, worth $3,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Previous 59 28.81%
Holding current value
$3,667
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$77.7 - $123.62 $1,320 - $2,101
-17 Reduced 28.81%
42 $4,000
Q2 2024

Jul 12, 2024

BUY
$58.87 - $83.05 $3,473 - $4,899
59 New
59 $4,000
Q3 2022

Oct 17, 2022

BUY
$61.42 - $86.29 $7,800 - $10,958
127 New
127 $9,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.